Shock
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients meeting all of the following criteria will be included. 1. Admitted to the ICU within 24 hours 2. Aged 18 years or older 3. Requiring a continuous infusion of vasopressors (i.e., norepinephrine, vasopressin, epinephrine, phenylephrine, dopamine) to maintain the target blood pressure 4. Expected to stay in the ICU longer than 24 hours
Exclusion criteria
Exclusion criteria: Patients meeting either of the following criteria will be excluded. 1. History of primary or secondary aldosteronism 2. Active palliation 3. Pregnancy or lactation 4. Absence of informed consent from the study participant or their next of kin 5. Judgment of the treating physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 30-day mortality | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. ICU mortality 2. Major Adverse Kidney Events at day 30 (MAKE30) 3. Dependence on renal replacement therapy at day 30 4. Persistent renal dysfunction at day 30 5. Severe acute kidney injury at day 7 6. Days of alive and free from intravenous vasopressor therapy at day 30 | — |
Countries
Japan
Contacts
Kameda Medical Center Department of Intensive Care Medicine